Azelead Portfolio


is one of the most serious diseases in the developed world.
It causes 7 million deaths each year worldwide, mostly as a result of the development of secondary tumors (metastases).
Unfortunately, the generation of metastases in healthy tissue from a primary tumor is unpredictable and we still do not have an effective treatment to prevent the metastatic process.


uses zebrafish embryos to detect the real time stages of metastatic progression:
— Loss of cell polarity
— Cell motility
— Matrix degradation
— Migration through the extracellular matrix
— Intravasation/extravasation in blood vessels and proliferation in tissue.

Based on new state-of-the-art technology, AZELEAD has identified 3 new compounds capable of preventing metastasis and cancer progression in vivo.